Published in Arthritis Rheum on September 01, 1988
Ocular manifestations of systemic lupus erythematosus: a review of the literature. Autoimmune Dis (2012) 1.61
Retinal disease in patients with systemic lupus erythematosus. Ann Rheum Dis (2000) 1.45
Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis (1996) 1.27
Antiphospholipid syndrome: linking many specialties. Ann Rheum Dis (1989) 0.99
Ocular manifestation of systemic lupus erythematosus. Rheumatol Int (2011) 0.97
Retinal vasculitis in two pediatric patients with systemic lupus erythematosus: a case report. Pediatr Rheumatol Online J (2013) 0.91
Successful treatment of optic neuropathy in association with systemic lupus erythematosus using intravenous cyclophosphamide. Br J Ophthalmol (1997) 0.86
Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J (2009) 0.86
Subungual splinter haemorrhages: a new sign of the antiphospholipid coagulopathy? Ann Rheum Dis (1990) 0.85
Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol (2005) 0.84
Gender and ocular manifestations of connective tissue diseases and systemic vasculitides. J Ophthalmol (2014) 0.83
Retinal vasculitis in rheumatic diseases: an unseen burden. Clin Rheumatol (2012) 0.82
Retinal vasculitis--a primer. West J Med (1991) 0.81
Severe bilateral necrotising retinitis caused by Toxoplasma gondii in a patient with systemic lupus erythematosus and diabetes mellitus. Br J Ophthalmol (2003) 0.80
Autoimmune retinopathy in systemic lupus erythematosus: histopathologic features. Open Ophthalmol J (2009) 0.79
Anticardiolipin antibody negative occlusive vascular retinopathy in systemic lupus erythematosus. Ann Rheum Dis (1990) 0.78
ERG findings in patients using hydroxychloroquine. Doc Ophthalmol (2004) 0.78
Laser in situ keratomileusis in patients with collagen vascular disease: a review of the literature. Clin Ophthalmol (2012) 0.76
Role of lupus retinopathy in systemic lupus erythematosus. J Ophthalmic Inflamm Infect (2016) 0.75
Rheumatology. Postgrad Med J (1991) 0.75
Acute necrotizing retinal vasculitis as onset of systemic lupus erythematosus: A case report. Medicine (Baltimore) (2017) 0.75
Comment on the article by Stafford-Brady et al. Arthritis Rheum (1989) 0.75
Rash and loss of vision in a 60-year-old woman with systemic lupus erythematosus. CMAJ (2011) 0.75
Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus. Int Med Case Rep J (2015) 0.75
Occlusive ocular vascular disease and antiphospholipid antibodies. Ann Rheum Dis (1990) 0.75
Coexistence of ankylosing spondylitis and undifferentiated connective tissue disease. Clin Rheumatol (1998) 0.75
[Choroidal vascular occlusion]. Ophthalmologe (2011) 0.75
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum (1992) 14.73
Methods for assessing responsiveness: a critical review and recommendations. J Clin Epidemiol (2000) 5.01
Eye injuries in squash: a preventable disease. Can Med Assoc J (1978) 4.15
Mortality in systemic lupus erythematosus. Arthritis Rheum (2006) 3.61
The bimodal mortality pattern of systemic lupus erythematosus. Am J Med (1976) 3.47
Psoriatic arthritis precipitated by physical trauma. J Rheumatol (1990) 2.70
Accelerated nodulosis, pleural effusion, and pericardial tamponade during methotrexate therapy. J Rheumatol (1994) 2.62
The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum (1997) 2.49
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients. Ann Rheum Dis (2004) 2.47
Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum (1997) 2.40
Eye injuries in racquet sports: a continuing problem. Can Med Assoc J (1980) 2.34
The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol (2000) 2.26
Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum (2007) 2.18
Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med (1977) 2.09
Methotrexate in systemic lupus erythematosus. J Rheumatol (1994) 2.08
Ruptured globes following radial and hexagonal keratotomy surgery. Arch Ophthalmol (1996) 2.06
Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum (2001) 2.04
Vitamin D insufficiency in a large female SLE cohort. Lupus (2009) 2.02
Detection of color vision defects in chloroquine retinopathy. Ophthalmology (1999) 2.00
Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum (1992) 1.88
Treatment recommendations for psoriatic arthritis. Ann Rheum Dis (2008) 1.85
HLA antigens in psoriatic arthritis. J Rheumatol (1986) 1.69
Vascular events in hypertensive patients with systemic lupus erythematosus. Lupus (2000) 1.59
The systemic effects of intra-articular corticosteroid. J Rheumatol (1974) 1.57
Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol (2000) 1.57
Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol (2001) 1.56
Venous syndromes and pulmonary embolism in systemic lupus erythematosus. Ann Rheum Dis (1980) 1.52
HLA-D region genes and rheumatoid arthritis (RA): importance of DR and DQ genes in conferring susceptibility to RA. Ann Rheum Dis (1992) 1.52
How to improve morbidity and mortality in systemic lupus erythematosus. Rheumatology (Oxford) (2000) 1.52
Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol (1995) 1.52
Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol (1996) 1.50
Association of a specific ERAP1/ARTS1 haplotype with disease susceptibility in ankylosing spondylitis. Arthritis Rheum (2009) 1.46
Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus. Ann Rheum Dis (2008) 1.45
Psoriatic arthritis and imaging. Ann Rheum Dis (2005) 1.44
The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. J Rheumatol (1995) 1.43
Psoriatic arthritis imaging: a review of scoring methods. Ann Rheum Dis (2005) 1.42
Morbidity in systemic lupus erythematosus. J Rheumatol Suppl (1987) 1.41
Comparison of radiological severity in psoriatic arthritis and rheumatoid arthritis. J Rheumatol (2001) 1.40
CARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritis. Am J Hum Genet (2003) 1.38
Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol (1994) 1.35
Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol (1997) 1.34
Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol (1992) 1.34
The lupus activity criteria count (LACC). J Rheumatol (1984) 1.34
The nature and outcome of infection in systemic lupus erythematosus. Lupus (2002) 1.34
Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum (2008) 1.34
Accurately describing changes in disease activity in Systemic Lupus Erythematosus. J Rheumatol (2000) 1.31
Systemic lupus erythematosus in males. Medicine (Baltimore) (1983) 1.29
Mortality studies in systemic lupus erythematosus. Results from a single center. II. Predictor variables for mortality. J Rheumatol (1995) 1.29
Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q J Med (1985) 1.28
Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus. Ann Rheum Dis (2007) 1.28
Increased frequency of HLA-DR5 in scleroderma. Arthritis Rheum (1981) 1.27
Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis (2009) 1.27
Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry. Rheumatoid Arthritis Azathioprine Registry Steering Committee. J Rheumatol (1991) 1.27
Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme. J Rheumatol (1985) 1.27
HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum (1992) 1.27
Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus (2001) 1.26
Neuropsychiatric lupus. J Rheumatol (1980) 1.25
Eye injuries associated with war games. CMAJ (1985) 1.25
Felty's syndrome. Clinical and serological analysis of 34 cases. Ann Rheum Dis (1977) 1.24
Impaired antigen-specific suppressor cell activity in psoriasis and psoriatic arthritis. J Invest Dermatol (1981) 1.23
Serum antibody to double-stranded RNA and DNA in patients with idiopathic and secondary uveitis. N Engl J Med (1971) 1.23
Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol (1995) 1.23
Azathioprine in rheumatoid arthritis: a long-term follow-up study. Arthritis Rheum (1975) 1.22
Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2. Arthritis Rheum (2007) 1.21
Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis (2005) 1.21
Investigating the genetic basis for ankylosing spondylitis. Linkage studies with the major histocompatibility complex region. Arthritis Rheum (1994) 1.20
Lupus and pregnancy studies. Arthritis Rheum (1993) 1.20
Radiological assessment in psoriatic arthritis. Br J Rheumatol (1998) 1.20
Malignancy in systemic lupus erythematosus. Arthritis Rheum (1996) 1.19
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. J Rheumatol (1994) 1.17
Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol (1997) 1.17
A modified version of the Health Assessment Questionnaire (HAQ) for psoriatic arthritis. Clin Exp Rheumatol (1995) 1.16
Systemic lupus erythematosus with negative LE cells and antinuclear factor. J Rheumatol (1978) 1.16
Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am J Med (1979) 1.15
Postdiarrheal arthropathy of Yersinia pseudotuberculosis. Can Med Assoc J (1978) 1.15
Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J Rheumatol (1999) 1.14
Azathioprine in early rheumatoid arthritis. Comparison with gold and chloroquine. Arthritis Rheum (1977) 1.13